Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo - Wikidata - wikimedia - TriplyDB

Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo

Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo

http://www.wikidata.org/entity/Q34719926

about

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria Malaria epidemiological research in the Republic of Congo Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries Atypical aetiology of a conjugal fever: autochthonous airport malaria between Paris and French Riviera: a case report.A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire)Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.Low Prevalence of Pfcrt Resistance Alleles among Patients with Uncomplicated Falciparum Malaria in Niger Six Years after Chloroquine Withdrawal.Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay In vitro assessment of drug resistance in Plasmodium falciparum in five States of India.Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011 Environmental determinant of malaria cases among travellers Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo Antimalarial efficacy of hydroxyethylapoquinine (SN-119) and its derivatives In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.Pharmacodynamics of antimalarial chemotherapy.Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance.Resistance to dihydroartemisinin.Determinants of Adherence with Malaria Chemoprophylactic Drugs Used in a Traveler's Health Clinic.

P2860

Q24614989-3065D3B2-81C4-483A-9719-7337C45F7036 Q28068644-8111DF10-9252-46EA-965B-7AEFD0606019 Q28477846-F52B9EA4-8DDD-4449-A841-4F8A2DE73D17 Q28534753-177F9AD0-DDC1-474B-81E3-9999D29DA3F1 Q33385921-E5A803AE-E1AC-4BD2-98D4-066507F46623 Q33562855-6A44EB00-9315-439F-9B5D-C1E255139F65 Q33676088-2F5FB446-FADF-474E-BB48-53E53636F9E1 Q33690072-D420F927-5C9C-4B54-909E-B7D3FF71E6AD Q34206442-D2DDE5BC-6BA6-4B28-B42C-464C0136E560 Q34529355-26F60F35-CA77-484B-9E3D-4AA7543AE466 Q34541163-D9312A08-715C-4C25-A256-03BCC1C19A83 Q34601191-1D308990-B12D-4791-8016-18E36ED05D17 Q34651627-DE491FC7-6859-4962-A439-5DF8DDBEC51B Q35533577-9B345918-1B0E-47A3-9D5C-2A80CAEF8A98 Q35701564-F42EFE06-1D5C-460C-A433-C8C608831861 Q35757486-E05E5513-29E6-401F-A28C-2F930001A6F9 Q36064289-335E1785-E2F8-4E11-9118-D2C781752DB2 Q36643101-72CF0AF5-F44E-4C61-826C-348F017A95F4 Q36689607-AB97822A-391F-46E9-90C5-E882F343C9AF Q36969710-E9497540-CF7F-40EE-8432-ED2D2AB6F7D7 Q37184295-6E3CDF28-7FA2-483D-9074-82C2315E8D15 Q37272095-CC0275BE-F1EA-4E1C-918D-ACFC5E6C7D8F Q37436582-40FB67DE-CE36-4A56-BDA0-4BA9889D8D25 Q37544298-50D38946-6E98-4506-AD03-46FEEA9AF8CE Q41833044-290DBAF3-6A2E-4FB6-8E27-1819D14ED613 Q41907557-8BBEFA12-80B2-47D4-95C7-6061EA6AC0A7 Q41935745-3C2DF10B-50E4-424D-BE51-4F680FF1976A Q41937598-28639ED9-6F7A-49D6-A189-2EB2FD4A8573 Q41937695-64DEFF1F-1BCC-4F8C-A47E-B92793DEE761 Q41943366-C033B110-4F10-4417-9890-53DDE03B5AAE Q42761238-50C3D3AA-1A74-4EF0-B164-25F3D73D4F9E Q43115905-A478BF0E-AD4E-4B18-9BC9-C628666A2DE7

P2860

Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo

http://www.wikidata.org/entity/Q34719926

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@ast

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@en

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@nl

type

label

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@ast

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@en

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@nl

prefLabel

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@ast

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@en

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@nl

P1433

Q34719926-6AED3177-BD8F-4F31-80A7-9EC4AFD386A1

P1476

Q34719926-0B04CD45-B413-4097-80DB-05F812C8E600

P2093

Q34719926-0DF64DE9-4122-475D-AC15-0A332BC08C2A

Q34719926-0F79E1D2-71A1-4238-9A70-11380D376E03

Q34719926-175023EE-3E16-4D16-9606-EFE441FE2AF6

Q34719926-28C14028-51CB-4094-9717-38BAB99CCB39

Q34719926-399BA7A8-0910-44CF-918E-44811316E964

Q34719926-44573C69-1630-48A1-A7CD-3B6965992F23

Q34719926-5ADDCD09-6D6F-4639-A2C9-7507F888F5BA

Q34719926-7380F600-A6BB-4BBD-A7C4-A762AF29D3DB

Q34719926-954C1E53-58BB-4DFA-BAEC-6E024EC88B69

Q34719926-A4041881-D7BE-4C21-8B5A-83EECE5E6FC6

P2860

Q34719926-1154A170-20F7-41D5-A051-E4040DC0765E

Q34719926-118DDA36-B279-4DAE-AC71-9C9A1F28C3DF

Q34719926-1346A326-8222-4300-BF42-544D877A5468

Q34719926-1434BA6C-9952-404C-A0A9-604FAFEDA043

Q34719926-15DB64C3-122A-4A5F-92AD-5B9B65A6947C

Q34719926-18041FBD-9307-4D3E-B188-C48AD5FB1636

Q34719926-19C789DA-9691-4F83-AA2F-FE2EEFB16F64

Q34719926-28FD8D78-0546-4699-8FE7-AFC0D53650CB

Q34719926-36C8177E-EBC0-4744-A2B6-175B1C015EC4

Q34719926-3D8B88FF-892B-4E7A-BC24-AE82C9FCF6CC

P304

Q34719926-148BE910-537C-4D12-B9C1-FCFAB4D100E3

P31

Q34719926-B3F09C68-4D2D-41B4-A701-D7321E5C32CF

P356

Q34719926-6957BE89-0FED-424E-B032-57009124EEFA

P407

Q34719926-C4E9C0B5-60D5-4859-9048-0684A54E1DB5

P433

Q34719926-6F265579-CBF5-4E60-911F-A5F6DE34DCF5

P478

Q34719926-72EA28E9-FEDB-4300-BAE2-9335F26DFC16

P50

Q34719926-12B6B5CC-CEA6-4325-8413-A6BFA0174CDB

Q34719926-FE036850-878A-4D1C-89AA-C6EBEAAF3157

P577

Q34719926-8AAF6FE9-43D1-4804-A4C8-4387852B1ED7

P5875

Q34719926-51CE3836-2A8D-4FF4-9A99-437DD9672E96

P698

Q34719926-E49515BA-A0F1-46BA-AAFF-41C39E1297B6

P921

Q34719926-4C57AB50-B42C-4732-9CC6-70AADECDDD9A

Q34719926-EAA3BDC7-FAFC-4317-9F6E-D00466308BE8

P932

Q34719926-AFB45372-C7A3-40CF-AF90-B60E0762D6AE

P356

P1433

Journal of Clinical Microbiology

P1476

Prevalence of in vitro resista ...... e-Noire, Republic of the Congo

@en

P2093

Alain Callec

http://www.w3.org/2001/XMLSchema#string

Eric Baret

http://www.w3.org/2001/XMLSchema#string

Henri Léonard Atanda

http://www.w3.org/2001/XMLSchema#string

Jean Pierre Gardair

http://www.w3.org/2001/XMLSchema#string

Joel Mosnier

http://www.w3.org/2001/XMLSchema#string

Julien Cren

http://www.w3.org/2001/XMLSchema#string

Philippe Cheval

http://www.w3.org/2001/XMLSchema#string

Philippe Hovette

http://www.w3.org/2001/XMLSchema#string

Rémy Amalvict

http://www.w3.org/2001/XMLSchema#string

Thierry Fusai

http://www.w3.org/2001/XMLSchema#string

P2860

Synchronization of Plasmodium falciparum erythrocytic stages in culture

Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.

In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.

Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal.

[Surveillance of the in vivo sensitivity of Plasmodium falciparum to antimalarial agents: the results of initial tests of the OCEAC Malaria Network]

[Plasmodium falciparum chemoresistance. The situation in Africa in 1989]

Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.

Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.

A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.

P304

2404-2408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00623-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Rogier

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6960495

http://www.w3.org/2001/XMLSchema#string

P698

16825356

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

1489504

http://www.w3.org/2001/XMLSchema#string